Clinical trial
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
NCT06550024 is registered in ClinicalTrials.gov with CrannMed as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
- Lead sponsor
- CrannMed
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 28, 2024
- Completion date
- October 31, 2028
- Enrollment
- 89 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
arthritis, joint diseases, musculoskeletal diseases, osteo arthritis knee, osteoarthritis, rheumatic diseases